6-143713902-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001100164.2(PHACTR2):c.214+1719C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.48 in 151,896 control chromosomes in the GnomAD database, including 17,701 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.48 ( 17701 hom., cov: 32)
Consequence
PHACTR2
NM_001100164.2 intron
NM_001100164.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0930
Publications
6 publications found
Genes affected
PHACTR2 (HGNC:20956): (phosphatase and actin regulator 2) Predicted to enable actin binding activity. Predicted to be involved in actin cytoskeleton organization. Predicted to be located in plasma membrane and platelet alpha granule membrane. Implicated in Parkinson's disease and multiple sclerosis. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Apr 2022]
PHACTR2 Gene-Disease associations (from GenCC):
- dilated cardiomyopathyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.522 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.480 AC: 72778AN: 151778Hom.: 17676 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
72778
AN:
151778
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.480 AC: 72860AN: 151896Hom.: 17701 Cov.: 32 AF XY: 0.477 AC XY: 35440AN XY: 74232 show subpopulations
GnomAD4 genome
AF:
AC:
72860
AN:
151896
Hom.:
Cov.:
32
AF XY:
AC XY:
35440
AN XY:
74232
show subpopulations
African (AFR)
AF:
AC:
17852
AN:
41400
American (AMR)
AF:
AC:
6755
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1772
AN:
3468
East Asian (EAS)
AF:
AC:
2225
AN:
5168
South Asian (SAS)
AF:
AC:
2595
AN:
4814
European-Finnish (FIN)
AF:
AC:
4851
AN:
10524
Middle Eastern (MID)
AF:
AC:
161
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35077
AN:
67922
Other (OTH)
AF:
AC:
1041
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1969
3939
5908
7878
9847
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
662
1324
1986
2648
3310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1870
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.